Drug Topics
MARCH 27, 2025
Lauren Angelo, PharmD, MBA, discussed current vaccination sentiments across the country and how misinformation has contributed to declining rates among US patients.
STAT
MARCH 27, 2025
WASHINGTON — Sen. Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr. as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines. On Thursday morning, Cassidy said, the two had breakfast to discuss Kennedy’s plans to lay off 10,000 Health and Human Services Department employees.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 21, 2025
Sally Arif, PharmD, professor in the College of Pharmacy at Midwestern University, discusses how pharmacists can effectively communicate with diverse patients.
The Guardian - Pharmaceutical Industry
MARCH 22, 2025
Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
MARCH 25, 2025
As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.
PhRMA
MARCH 24, 2025
A new report by the Wall Street Journal reveals abuse of the 340B hospital markup program is getting worse as hospitals and middlemen find new ways to profit off the program.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 27, 2025
WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are. The Health and Human Services Department on Thursday announced a sweeping plan to cut 10,000 jobs and consolidate operations across its sub-agencies. FDA drug, medical device, or food reviewers and inspectors will not be among those fired, according to an HHS fact sheet.
OctariusRx
MARCH 24, 2025
Two of the top four CMS deficiencies in Ambulatory Surgery Centers last year were related to medication management. As we know, medication management citations fall under various sections of the CMS requirements (Conditions For Coverage). There isnt just one single section on medications in the CMS document, so knowing your way around the requirements is essential to ensure compliance with each element of safe medication management.
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Pharma Marketing Network
MARCH 27, 2025
Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 27, 2025
Over a decade ago, psychologist and researcher Jae Sevelius had an idea: The behaviors that might put transgender people at particularly high risk of getting HIV stem from the fact that their gender wasn’t being affirmed as they needed. If that could happen more easily for people — with good medical care, but also through validation from family, friends, and society — they’d be healthier overall, and less likely to engage in risky behavior that could put them at
The Checkup by Singlecare
MARCH 25, 2025
Bupropion , commonly marketed under the brand names Wellbutrin SR, Wellbutrin XL, and Zyban, is an oral medication used for treating adult depression and seasonal affective disorder (SAD). SAD is a form of depression that occurs in a recurrent seasonal pattern and is more common or severe during winter. Bupropion is also approved by the Food and Drug Administration (FDA) as a medication for aiding smoking cessation.
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
Pharma Marketing Network
MARCH 25, 2025
Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
MARCH 21, 2025
Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses initiating anticoagulation for older adults as well as the risk-benefit balance of the therapy.
STAT
MARCH 27, 2025
When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.
PhRMA
MARCH 28, 2025
Intellectual property (IP) protections are the foundation of U.S. global leadership in biopharmaceutical innovation. Patents and other IP protections over the past 25 years have fueled the delivery of over 750 new medicines for debilitating and devastating illnesses, such as cancer, heart disease and many rare diseases, by giving innovators the legal protection and confidence they need to take on the significant costs and risks associated with drug development.
PharmaVoice
MARCH 28, 2025
The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MARCH 21, 2025
Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.
Drug Topics
MARCH 25, 2025
Alisha Reed, PharmD, founder of Your Self Care Prescription, LLC, discussed how pharmacists can implement wellness programs to reduce burnout.
STAT
MARCH 25, 2025
23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.
The Guardian - Pharmaceutical Industry
MARCH 21, 2025
Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.
DiversifyRx
MARCH 27, 2025
Dont Get Burned: What Every Pharmacy Owner Needs to Know About Diabetic Testing Supplies Lets talk about something thats come up in multiple conversations with pharmacy owners latelyand its a topic you cant afford to ignore: diabetic testing supplies. Whether youre billing Medicare, selling to cash patients, or stocking your shelves for convenience, diabetic testing supplies can be a reliable source of revenue.
Pharmacy Times
MARCH 21, 2025
The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.
Drug Topics
MARCH 22, 2025
Dan Krinsky, BS, MS, RPh, FAPhA, and Stefanie Ferreri, PharmD, BCACP, FAPhA, discussed new OTC product releases, recalls, and other updates pharmacists should be aware of.
STAT
MARCH 27, 2025
Both deputy directors at the key Food and Drug Administration center that oversees the regulation of cancer drugs plan on departing the agency, sources told STAT Thursday, highlighting the drain on talent at the FDA created by layoffs, uncertainty, and shifts in policy at the agency even as it is set to lay off thousands more people. Both Paul G. Kluetz, who joined the FDA as a medical reviewer in 2016, and Marc R.
PharmaVoice
MARCH 27, 2025
Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.
Fierce Healthcare
MARCH 26, 2025
The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.
Pharmacy Times
MARCH 23, 2025
In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s advantages in stroke prevention and weight loss vs SGLT2s superiority in heart failure, CV death reduction, and renal protection.
Drug Topics
MARCH 23, 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the various errors patients experience when using CGM devices.
STAT
MARCH 24, 2025
Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.
PharmaVoice
MARCH 27, 2025
After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.
Pharmafile
MARCH 27, 2025
Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in pharmaceutical products in the EU-27. Furthermore, trade from Ireland to Belgium, from Germany to the Netherlands and from the Netherlands to Germany occupy the highest trade positions. Logista Freight is a logistics company which specialises […] The post Five of EU-27 account for 68% of pharma trade, report finds appeared first on Pharmafile.
Expert insights. Personalized for you.
486 
Let's personalize your content